|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Clinical Features of Adult/Adolescent Atopic Dermatitis and Chinese Criteria for Atopic Dermatitis显示文摘 | Ping Liu Yan Zhao Zhang-Lei Mu Qian-Jin Lu Qian-Jin L U Li Zhang Xu Yao Min Zheng Yi-Wen Tang Xin-Xiano Lu Xiu-Juan xia You-Kun Lin Yu-Zhen Li Cai-Xia Tu Zhi-Rong Yao Jin-Hua Xu Wei Li Wei Lai Hui-Min Yang Hong-Fu Xie Xiu-Ping Han Zhi-Qiang Xie Xiang Nong Zai-Pei Guo Dan-Qi Deng Tong-Xin Shi Jian-Zhong Zhang | 2016 | Chinese Medical Journal2016，，7： | 64 |
| 2 | Mesenchymal stem cells derived from human placenta suppress allogeneic umbilical cord blood lymphocyte proliferation显示文摘ABSTRACTHuman placenta-derived mononuclear cells (MNC) were isolated by a Percoll density gradient and cultured in mesen-chymal stem cell (MSC) maintenance medium. The homogenous layer of adherent cells exhibited a typical fibroblast-like morphology, a large expansive potential, and cell cycle characteristics including a subset of quiescent cells. In vitrodifferentiation assays showed the tripotential differentiation capacity of these cells toward adipogenic, osteogenic andchondrogenic lineages. Flow cytometry analyses and immunocytochemistry stain showed that placental MSC was ahomogeneous cell population devoid of hematopoietic cells, which uniformly expressed CD29, CD44, CD73, CD105,CD166, laminin, fibronectin and vimentin while being negative for expression of CD31, CD34, CD45 and α-smoothmuscle actin. Most importantly, immuno-phenotypic analyses demonstrated that these cells expressed class I majorhistocompatibility complex (MHC-I), but they did not express MHC-II molecules. Additionally these cells could sup-press umbilical cord blood (UCB) lymphocytes proliferation induced by cellular or nonspecific mitogenic stimuli. Thisstrongly implies that they may have potential application in allograft transplantation. Since placenta and UCB arehomogeneous, the MSC derived from human placenta can be transplanted combined with hematopoietic stem cells(HSC) from UCB to reduce the potential graft -versus-host disease (GVHD) in recipients. | Chang Dong LI Wei Yuan ZHANG He Lian LI Xiao Xia JIANG Yi ZHANG Pei Hsien TANG Ning MAO | 2005 | Cell Research2005，15，7： | 36 |
| 3 | China National Medical Products Administration approval summary:anlotinib for the treatment of advanced non-small cell lung cancer after two lines of chemotherapy显示文摘Background:On May 8,2018,the China National Medical Products Administration(NMPA)approved anlotinib,an orally administered anti-angiogenesis inhibitor,for the treatment of patients with advanced non-small cell lung can-cer(NSCLC)who have progressed after treatment with two or more lines of prior systemic chemotherapy.Main body of the abstract:China NMPA reviewed and inspected a regional double-blinded,placebo-controlled,Phase III trial comparing the overall survival(OS)of NSCLC patients between the anlotinib and placebo arms.A total of 437 patients were randomized(2:1)to receive either anlotinib(n=294)or placebo(n=143)once daily on a 2-week on and 1-week off schedule.Patients with epidermal growth factor receptor(EGFR)or activating anaplastic lymphoma kinase(ALK)genomic tumor aberrations should have disease progression on NMPA-approved therapy.Anlotinib is the first NMPA-approved drug for patients with advanced NSCLC who have progressed on at least two lines of prior systemic chemotherapies in China.The approval was based on a statistically and clinically significant improvement in median OS with anlotinib(9.46 months)compared with placebo[6.37 months;hazard ratio(HR])=0.70,95%confidence interval(CI)=0.55-0.89;two-sided log-rank P=0.002].The confirmed objective response rate(ORR)was 9.2%in the anlotinib arm and 0.7%in the placebo arm.The median duration of response(DoR)was 4.83 months,with a 95%CI of 3.31-6.97 months.The toxicity profile of anlotinib was consistent with that of known anti-angiogenesis inhibitors.Common adverse drug reactions(ADRs)in anlotinib-treated patients included hypertension(67.4%),hand-foot syndrome(43.9%),hemoptysis(14.0%),thyroid stimulating hormone(TSH)elevation(46.6%),and corrected QT interval(QTc)prolongation(26.2%).Short conclusion:Anlotinib demonstrated a clinically significant OS prolongation as a novel therapeutic option for advanced or metastatic NSCLC following at least two lines of chemotherapy. | Ming Zhou Xiaoyuan Chen Hong Zhang Lin Xia Xin Tong Limin Zou Ruimin Hao Jianhong Pan Xiao Zhao Dongmei Chen Yuanyuan Song Yueli Qi Ling Tang Zhifang Liu Rong Gao Yuankai Shi Zhimin Yang | 2019 | Cancer Communications2019，39，1： | 35 |
| 4 | A study of interaction between surface water and groundwater using environmental isotope in Huaisha River basin显示文摘The surface water and groundwater are important components of water cycle, and the interaction between surface water and groundwater is the important part in water cycle research. As the effective tracers in water cycle research, environmental isotope and hydrochemistry can reveal the interrelationships between surface water and groundwater effectively. The study area is the Huaisha River basin, which is located in Huairou district, Beijing. The field surveying and sampling for spring, river and well water were finished in 2002 and 2003. The hydrogen and oxygen isotopes and water quality were measured at the laboratory. The spatial characteristics in isotope and evolution of water quality along river lines at the different area were analyzed. The altitude effect of oxygen isotope in springs was revealed, and then using this equation, theory foundation for deducing recharge source of spring was estimated. By applying the mass balance method, the annual mean groundwater recharge rate at the catchment was estimated. Based on the groundwater recharge analysis, combining the hydrogeological condition analysis, and comparing the rainfall-runoff coefficients from the 1960s to 1990s in the Huaisha River basin and those in the Chaobai River basin, part of the runoff in the Huaisha River basin is recharged outside of this basin, in other words, this basin is an un-enclosed basin. On the basis of synthetically analyses, combining the compositions of hydrogen and oxygen isotopes and hydrochemistry, geomorphology, geology, and watershed systems characteristics, the relative contributions between surface water and groundwater flow at the different areas at the catchments were evaluated, and the interaction between surface water and groundwater was re- vealed lastly. | SONG Xianfang1, LIU Xiangchao1, 2, XIA Jun1, YU Jingjie1 & TANG Changyuan1, 3 1. Key Laboratory of Water Cycle and Related Land Surface Processes, Institute of Geographical Sciences and Natural Re- sources Research, Chinese Academy of Sciences, Beijing 100101, China 2. College of River and Ocean, Chongqing Jiaotong University, Chongqing 400074, China 3. Chiba University, Chiba 263-8522, Japan | 2006 | Science China Earth Sciences2006，49，12： | 34 |
| 5 | Metastatic human hepatocellular carcinoma models in nude mice and cell line with metastatic potential显示文摘Metastatic human HCC model is needed for the studies on mechanism and intervention of metastatic recurrence. By using orthotopic implantation of histologically intact tissues of 30 surgical specimens, a patient like metastatic model of human HCC in nude mice (LCI-D20)and a Iow metastatic model of human HCC in nude mice LCI-D35 ) have been established. All mice with transplanted LCI-D20 tumors exhibited extremely high metastatic ability including spontaneous metastasis to liver, lungs, lymph nodes and peritoneal seeding.Remarkable difference was also found in expression of some of the invasiveness related genes and growth factors between the LCI-D20 and LCI-D35 tumors. PAI-Iincreased gradually following tumor progression in LCID20 model, and correlated with tumor size and AFP level,Phasic expression of tissue intercellular adhesion molecule-I in this model was also observed. Using corneal micropocket model, it was demonstrated that the vascular response induced by LCI-D20 tumor was stronger than that induced by LCI-D35 tumor. Similar report on metastatic human HCC model in nude mice and human HCC cell line with metastatic potential was rarely found in the literature. This LCI-D20 model has been widely used for the studies on intervention of metastasis, including antiangiogenesis, antisense approach, metalloproteinase inhibitor, differentiation inducer, etc. It is concluded that the establishment of metastatic human HCC model in nude mice and human HCC cell line with metastatic potential will provide important models for the in vivo and in vitro study of HCC invasiveness, angiogenesis as well as intervention of HCC recurrence. | Zhao-You Tang Fan-Xian Sun Jian Tian Sheng-Long Ye Yin-Kun Liu Kang-Da Liu Qiong Xue Jie Chen Jing-Lin Xia Lun-Xiu Qin Hui-Chuan Sun Lu Wang Jian Zhou Yan Li Zeng-Chen Ma Xin-Da Zhou Zhi-Quan Wu Zhi-Ying Lin Bing-Hui Yang Liver Cancer Institute of Fudan University and Zhongshan Hospital,Shanghai 200032,China | 2001 | World Journal of Gastroenterology2001，7，5： | 34 |
| 6 | Comparison of bupivacaine, ropivacaine and levobupivacaine with sufentanil for patient-controlled epidural analgesia during labor: a randomized clinical trial显示文摘背景 Ropivacaine 和 levobupivacaine 与与 bupivacaine 相比引起更少的马达块和毒性的建议优点被介绍了进产科的止痛实践。然而,麻药是否两个都为劳动痛觉缺失相对 bupivacaine 与任何临床的利益被联系,仍然是争论的。这研究试图为控制病人的硬膜上的劳动痛觉缺失在更低的集中比较止痛功效,马达块和 bupivacaine, ropivacaine 和 levobupivacaine 的副作用。450 从未生育过者的 parturients 在这使随机化的临床的试用被注册的方法。0.05% 任何一个 bupivacaine, 0.075% , 0.1% , 0.125% 或 0.15%( 组 B ) 的集中, ropivacaine (组 R ) 或有 sufentanil 的 levobupivacaine (组 L ) 0.5 g/ml 被控制病人的痛觉缺失硬膜上地管理模式。因为一个视觉类似物规模分数是 30 公里,有效痛觉缺失被定义。为每局部麻醉的相对中部的力量用一个概率单位回归模型被计算。Parturients 人口分布,感觉并且马达封锁,产科的数据,母亲的副作用,时时,使用的局部麻醉的体积,和其它也被注意。在那里的结果不是在在有效痛觉缺失的数字的组之中的重要差别,疼痛分数,时时,局部麻醉数量使用了,感觉并且马达封锁,劳动持续时间和交货,副作用和母亲的满足的模式(P > 0.05 ) 。相对中部的力量是 bupivacaine/ropivacaine:0.828 (0.602-1.091 ) , bupivacaine/levobupivacaine:0.845 (0.617-1.12 ) , ropivacaine/levobupivacaine:1.021 (0.774-1.354 ) 分别地。然而,一少些显著地时时有效痛觉缺失并且更高数局部麻醉使用在每个组以内 0.1% 比那些在 0.05% 的集中被观察(P < 0.05 ) 。用有 sufentanil 的控制病人的硬膜上的痛觉缺失, bupivacaine 的更低的集中, ropivacaine 和 levobupivacaine 的结论为劳动痛觉缺失生产类似的痛觉缺失和马达块和安全。止痛功效主要取决于集中而非麻药的类型。 | WANG Li-zhong CHANG Xiang-yang LIU Xia HU Xiao-xia TANG Bei-lei | 2010 | Chinese Medical Journal2010，，2： | 31 |
| 7 | Neuroprotective effect of bispectral index-guided fast-track anesthesia using sevoflurane combined with dexmedetomidine for intracranial aneurysm embolization显示文摘Dexmedetomidine has sedative, anxiolytic, analgesic, anti-sympathetic, and anti-shivering effects. Dexmedetomidine might be effective in combination with sevoflurane for anesthesia, but prospective randomized controlled clinical trials with which to verify this hypothesis are lacking. In total, 120 patients who underwent embolization of an intracranial aneurysm were recruited from Anhui Provincial Hospital and Renmin Hospital of Wuhan University of China and randomly allocated to two groups. After intraoperative administration of 2% to 3% sevoflurane inhalation, one group of patients received pump-controlled intravenous injection of 1.0 μg/kg dexmedetomidine for 15 minutes followed by maintenance with 0.3 μg/kg/h until the end of surgery; the other group of patients only underwent pump-controlled infusion of saline. Bispectral index monitoring revealed that dexmedetomidine-assisted anesthesia can shorten the recovery time of spontaneous breathing, time to eye opening, and time to laryngeal mask removal. Before anesthetic induction and immediately after laryngeal mask airway removal, the glucose and lactate levels were low, the S100β and neuron-specific enolase levels were low, the perioperative blood pressure and heart rate were stable, and postoperative delirium was minimal. These findings indicate that dexmedetomidine can effectively assist sevoflurane for anesthesia during surgical embolization of intracranial aneurysms, shorten the time to consciousness and extubation, reduce the stress response and energy metabolism, stabilize hemodynamic parameters, and reduce adverse reactions, thereby reducing the damage to the central nervous system. | Chao-liang Tang Juan Li Zhe-tao Zhang Bo Zhao Shu-dong Wang Hua-ming Zhang Si Shi Yang Zhang Zhong-yuan Xia | 2018 | Neural Regeneration Research2018，13，2： | 32 |
| 8 | Terrestrial carbon sinks in China and around the world and their contribution to carbon neutrality显示文摘Enhancing the terrestrial ecosystem carbon sink(referred to as terrestrial C sink) is an important way to slow down the continuous increase in atmospheric carbon dioxide(CO_(2)) concentration and to achieve carbon neutrality target.To better understand the characteristics of terrestrial C sinks and their contribution to carbon neutrality,this review summarizes major progress in terrestrial C budget researches during the past decades,clarifies spatial patterns and drivers of terrestrial C sources and sinks in China and around the world,and examines the role of terrestrial C sinks in achieving carbon neutrality target.According to recent studies,the global terrestrial C sink has been increasing from a source of (-0.2±0.9) Pg C yr^(-1)(1 Pg=1015g)in the 1960s to a sink of (1.9±1.1) Pg C yr^(-1) in the 2010s.By synthesizing the published data,we estimate terrestrial C sink of 0.20–0.25 Pg C yr^(-1) in China during the past decades,and predict it to be 0.15–0.52 Pg C yr^(-1) by 2060.The terrestrial C sinks are mainly located in the mid-and high latitudes of the Northern Hemisphere,while tropical regions act as a weak C sink or source.The C balance differs much among ecosystem types:forest is the major C sink;shrubland,wetland and farmland soil act as C sinks;and whether the grassland functions as C sink or source remains unclear.Desert might be a C sink,but the magnitude and the associated mechanisms are still controversial.Elevated atmospheric CO_(2) concentration,nitrogen deposition,climate change,and land cover change are the main drivers of terrestrial C sinks,while other factors such as fires and aerosols would also affect ecosystem C balance.The driving factors of terrestrial C sink differ among regions.Elevated CO_(2) concentration and climate change are major drivers of the C sinks in North America and Europe,while afforestation and ecological restoration are additionally important forcing factors of terrestrial C sinks in China.For future studies,we recommend the necessity for intensive and long-term ecosystem C monitoring over broad geographic scale to improve terrestrial biosphere models for accurately evaluating terrestrial C budget and its dynamics under various climate change and policy scenarios. | Yuanhe Yang Yue Shi Wenjuan Sun Jinfeng Chang Jianxiao Zhu Leiyi Chen Xin Wang Yanpei Guo Hongtu Zhang Lingfei Yu Shuqing Zhao Kang Xu Jiangling Zhu Haihua Shen Yuanyuan Wang Yunfeng Peng Xia Zhao Xiangping Wang Huifeng Hu Shiping Chen Mei Huang Xuefa Wen Shaopeng Wang Biao Zhu Shuli Niu Zhiyao Tang Lingli Liu Jingyun Fang | 2022 | Science China(Life Sciences)2022，65，5： | 32 |
| 9 | Association of PINK1 and DJ-1 confers digenic inheritance of early-onset Parkinson's disease显示文摘 | Tang B Xiong H Sun P Zhang Y Wang D Hu Z Zhu Z Ma H Pan Q Xia JH Xia K Zhang Z | 2006 | 中国生物学文摘2006，20，8： | 30 |
| 10 | Endogenously generated sulfur dioxide and its vasorelaxant effect in rats^1显示文摘瞄准:现在的学习被设计探索硫二氧化物的内长的生产和本地化(那么在老鼠并且到的脉管的纸巾的 2)/aspartate aminotransferase 小径在孤立的大动脉的戒指,以及可能的机制上检验它的 vasorelaxant 效果。方法:内容在样品的 2 被与荧光察觉使用高效液体层析因此决定。Aspartate aminotransferase 活动和它的基因表示被一个酶的方法和量的 RT PCR 分别地测量。在主动脉的 Aspartate aminotransferase mRNA 地点被检测由在 situ 杂交。vasorelaxant 效果老鼠的孤立的大动脉的戒指上的 2 因此在 vitro 被调查。L 类型钙隧道 blocker, nicardipine,和 L 类型钙隧道收缩筋,海湾 K8644,被用来探索 2 因此由放松了大动脉的戒指的机制。结果:有的主动脉最高,在脉管的纸巾之中的 2 内容因此测试了(P<0.01 ) 。在 endothelial 层下面位于 endothelia 和脉管的光滑的肌肉房间的大动脉的 aspartate aminotransferase mRNA。而且, SO 2 衍生物的生理的剂量(Na 23/NaHSO3) 因此稍微放松了孤立的动脉戒指,而更高的剂量(1 12 mmol/L ) 以一种集中依赖者方式放松了戒指。有 nicardipine 的预告的处理消除了收缩新肾上素的戒指的 vasorelaxant 反应到那么 2 完全。有 nicardipine 左右 2 衍生物的孵化成功地阻止了海湾 K8644 导致的血管缩小。结论:内长 2 和它的衍生物因此让 vasorelaxant 工作其机制可能包含 L 类型钙隧道的抑制。 | Shu-xu DU Hong-fang JIN Ding-fang BU Xia ZHAO Bin GENG Chao-shu TANG Jun-bao DU | 2008 | Acta Pharmacologica Sinica2008，29，8： | 30 |
| 11 | Outbreak of Dengue Fever in Central China,2013显示文摘In 2013,the first dengue fever(DF) outbreak in central China was reported in the central of Henan province,northern temperate regions,although they have been sequentially recorded in Southern China.106 suspected DF cases were reported and 73 patients were confirmed dengue virus type 3(DEN-3) infections.62/392(15.8%) local health persons showed DEN antibodies positive.To this day Henan is the northernmost province in China which has been reported about outbreak of DF and what is important is that it warns us the endemic range of DF has been expanded geographically in China. | HUANG Xue Yong MA Hong Xia WANG Hai Feng DU Yan Hua SU Jia LI Xing Le TANG Xiao Yan MA Hong Peng ZU Bing Can ZHANG Qiao Hong CHEN Hao Min XU Bian Li | 2014 | Biomedical and Environmental Sciences2014，27，11： | 30 |
| 12 | Characteristic pattern of human prostatic growth with age显示文摘Aim:To study the characteristic pattern of the age-related growth of the human prostate gland.Methods:The volume (weight) of the prostate in 1,601 males,aged from newborn to 92 years,was determined by Bultrasonography.Results:Prostatic volume determination by B-ultrasonography in 1601 males (1301 normal subjects and 300 BPH patients) pointed out that the age-stratified growth of human prostate could be categorized into 4 life stages:(1) the first slow growing phase(from newborn to 9 years):the prostate grows slowly at a rate of 0.14g per year;(2)the first rapid growing phase (from 10 to 30 years):the prostate grows at a rate of 0.84g per year;(3)the second slow growing phase (from 30 to 50 years),the prostate grows at a rate of 0.21g per year;(4)the second rapid growing phase (from 50 to 90 years):the prostate grows at one of the following rates:in one group the growth rate is of 0.50g per year and in the other 1.20g per year,leading to benign prostatic hyperplasia(BPH).Conclusion:The volumes of the prostate are different in different age groups and it grows with age at different rates in four life phases.The prostate growth in phases can be expressed by the following equation:Y=19.36+1.36X'-0.58X'^2+0.33X'^3,where Y=prostate volume,X=age(up to 70 years),X'=(X-35.5)/10. | Shu-Jie XIA Xiao-Xin XU Jian-Bao TENG Chun-Xiao XU Xiao-Da TANG | 2002 | Asian Journal of Andrology2002，4，4： | 30 |
| 13 | Recent developments and future prospects of Vitreoscilla hemoglobin application in metabolic engineering显示文摘 | Zhang, L Li, YJ Wang, ZN Xia, Y Chen, WS Tang, KX | 2007 | 中国生物学文摘2007，21，10： | 25 |
| 14 | CD44v6 in peripheral blood and bone marrow of patients with gastric cancer as micro-metastasis显示文摘瞄准:为了检测 CD44 的表示,与能力相关在有胃的癌症并且到的病人的外部血和骨髓微转移推出它的临床的意义。方法:从有胃的癌症和 6 控制的 46 个病人的外科手术前的外部血和骨髓标本被 CD44v6mRNA 的半量的 RT-PCR 扩大学习。从有胃的癌症和 14 控制的 40 个病人的外科手术前、手术后的外部血标本被 CD44v6mRNA 的量的 RT-PCR 扩大在相应经期学习。结果:半量的 RT-PCR 扩大证明外部血和骨髓的那 CD44v6mRNA 表情在 39 是积极的(84.8%) 并且 40 (86.9%) 有胃的癌症的 46 个病人分别地。在外部血, CD44v6mRNA 表示为 diffuse 是积极的 32 个病人并且为 14 个病人的在 9 的肠的类型(64.3%) 的在 30 的类型(93.8%) 。在另一方面在骨髓, CD44v6mRNA 表示为 diffuse 是积极的 32 个病人并且为 14 个病人的在 10 的肠的类型(71.4%) 的在 31 的类型(96.9%) 。在弥漫的类型和肠的类型之间有有效差量。量的 RT-PCR 扩大证明 CD44v6mRNA 没在控制的外部血被表示, CD44v6mRNA 表示为在有胃的癌症的 40 个病人的外科手术前的外部血是积极的,从 4.9 x 10 的表示层次(8 )- 3.2 x 10 (11 ) copies/g RNA。在外部血的 CD44v6mRNA 的平均表示水平是 3.9 x 10 (10 ) copies/g RNA。在在在到 7.6 x 10 的从 5.5 x 10 增加的药品操作(6 )(9 ) 以后的胃的癌症病人的外部血的 CD44v6mRNA 的表示层次 copies/g RNA 和平均水平是 2.4 x 10 (8 ) copies/g RNA (图 3B )(P = 0.00496 ) 。在药品操作以后,表示水平显著地减少了。结论:为 CD44v6mRNA 的半量、量的 RT-PCR 扩大是为察觉的一个敏感、特定的方法在外部血和骨髓微转移,它可能被用作肿瘤负担和治疗学的效果的指示物。 | Dao-Rong Wang Guo-Yu Chen Xun-Liang Liu Yi Miao Jian-Guo Xia Lin-Hai Zhu Dong Tang | 2006 | World Journal of Gastroenterology2006，12，1： | 23 |
| 15 | Induction of apoptosis of human gastric carcinoma SGC-7901 cell line by 5,7-dihydroxy-8-nitrochrysin in vitro显示文摘AIM: To investigate the effect of 5, 7-dihydroxy-8- nitrochrysin (NOChR) on apoptosis of human gastric carcinoma SGC-7901 cell line. METHODS: SGC-7901 cells were cultured in vitro and the inhibitory effect of NOChR on proliferation of SGC-7901 cells was measured by using an MTT assay. NOChR-induced apoptosis rate of SGC-7901 cells was detected using flow cytometry (FCM) with PI staining. DNA ladder bands were observed by DNA agarose gel electrophoresis. The influence of NOChR on the proxisome proliferator-activated receptor-γ (PPARγ), Bcl-2 and Bax protein expression of SGC-7901 cells was analyzed by Western blot. RESULTS: MTT assay showed that NOChR markedly inhibited proliferation of SGC-7901 cells in a dose- dependent manner, and when IC50 was 4.14 μmol/L, the potency of NOChR was 10 times than that of lead compound, chrysin (ChR, IC50 was 40.56 μmol/L), and was similar to 5-fluorouracil (5-FU, IC50 was 4.51 μmol/L). FCM with propidium iodide (PI) staining demonstrated that the apoptosis rates of SGC-7901 cells treated with 1.25, 5.00 and 20.00 μmol/L NOChR for 48 h were 9.8% ± 0.2%, 36.8% ± 1.9% and 45.5% ± 3.5%, respectively, and were significantly higher when treated with 5.00 and 20.00 μmol/L NOChR than that with 20.00 μmol/L ChR (12.9% ± 1.5%). DNA agarose gel electrophoresis showed that treatment of SGC-7901 cells with 20.00 μmol/L NOChR for 48 h resulted in typical DNA ladder bands of DNA of SGC-7901 cells, which could be eliminated by treating with 10.00 μmol/L GW9662, a blocker of PPARγ. Western blot analysis revealed that after 24 h of treatment with 20.00 μmol/L NOChR, PPARgamma and Bax protein expression of SGC-7901 cells increased but Bcl-2 expression decreased; however, pre-incubation with 10.00 μmol/L GW9662 could efficiently antagonize and weaken the regulatory effect of 20.00 μmol/L NOChR on Bax and Bcl-2 protein expression of SGC-7901 cells. CONCLUSION: NOChR induces apoptosis of SGC-7901 cell lines by activating PPARγ and decreasing ratio of Bcl-2 to Bax. | Xiao-Hong Ai Xing Zheng Xiao-Qing Tang Li Sun Yang-Qin Zhang Yong Qin Hua-Qing Liu Hong Xia Jian-Guo Cao | 2007 | World Journal of Gastroenterology2007，13，28： | 22 |
| 16 | The Chinese Society of Clinical Oncology(CSCO)clinical guidelines for the diagnosis and treatment of nasopharyngeal carcinoma显示文摘Nasopharyngeal carcinoma(NPC)is a malignant epithelial tumor originating in the nasopharynx and has a high incidence in Southeast Asia and North Africa.To develop these comprehensive guidelines for the diagnosis and management of NPC,the Chinese Society of Clinical Oncology(CSCO)arranged a multi-disciplinary team comprising of experts from all sub-specialties of NPC to write,discuss,and revise the guidelines.Based on the findings of evidencebased medicine in China and abroad,domestic experts have iteratively developed these guidelines to provide proper management of NPC.Overall,the guidelines describe the screening,clinical and pathological diagnosis,staging and risk assessment,therapies,and follow-up of NPC,which aim to improve the management of NPC. | Ling-Long Tang Yu-Pei Chen Chuan-Ben Chen Ming-Yuan Chen Nian-Yong Chen Xiao-Zhong Chen Xiao-Jing Du Wen-Feng Fang Mei Feng Jin Gao Fei Han Xia He Chao-Su Hu De-sheng Hu Guang-Yuan Hu Hao Jiang Wei Jiang Feng Jin Jin-Yi Lang Jin-Gao Li Shao-Jun Lin Xu Liu Qiu-Fang Liu Lin Ma Hai-Qiang Mai Ji-Yong Qin Liang-Fang Shen Ying Sun Pei-Guo Wang Ren-Sheng Wang Ruo-Zheng Wang Xiao-Shen Wang Ying Wang Hui Wu Yun-Fei Xia Shao-Wen Xiao Kun-Yu Yang Jun-Lin Yi Xiao-Dong Zhu Jun Ma | 2021 | Cancer Communications2021，41，11： | 22 |
| 17 | Effects of endogenous sulfur dioxide on monocrotaline-induced pulmonary hypertension in rats显示文摘瞄准:现在的学习试图探索内长的硫二氧化物的保护的效果(那么在发展的 2) 单音响尾蛇(MCT ) 在老鼠导致了肺的高血压(PH ) 。方法:四十只 Wistar 老鼠随机被划分成接受 MCT 处理的 MCT 组,加 HDX 处理收到 MCT 的 MCT+L-aspartate-β-hydroxamate (HDX ) 组,收到 MCT 加的 MCT+SO 2 组 2 施主处理,和控制因此组织。意味着肺的动脉压力(mPAP ) ,在肺的动脉的结构的变化被评估。因此 2 内容, aspartate aminotransferase 活动,和基因表示被测量。Superoxide dismutase (草皮) ,谷胱甘肽 peroxidase (GSH-Px ) ,过氧化氢酶(猫) ,减少的谷胱甘肽(GSH ) ,氧化谷胱甘肽,和 malondialdehyde (MDA ) 层次是 assayed。结果:在显著地增加的 对待MCT 的老鼠, mPAP 和正确ventricle/(左 ventricle+septum )( P<0.01 ),肺脉管的结构的改变发展了,并且肺 homogenates 的草皮, GSH-Px ,猫, GSH ,和 MDA 层次显著地增加了 P<0.01 )与联合那么提高了2内容, aspartate aminotransferase 活动,和基因表示,与控制老鼠相比。,在对待 MCT+HDX 的老鼠,肺纸巾和血浆, 2 内容和 aspartate aminotransferase 活动因此显著地减少了 mPAP 并且肺脉管的结构的改变显著地与对待 MCT 的老鼠(P<0.01 ) 相比与肺织物 homogenates 的减少的草皮,猫,和 GSH 层次被加重。相反,与使用一那么 2 施主,肺脉管的结构的改变显然与提高的肺织物草皮, GSH-Px,和 MDA 内容被减少,并且血浆草皮, GSH-Px,和猫铺平。结论:内长 2 可能因此在导致 MCT 的 PH 的致病起一个保护的作用并且支持内长的抗氧化的能力。 | Hong-fang JIN Shu-xu DU Xia ZHAO Hong-ling WEI Yan-fei WANG Yin-fang LIANG Chao-shu TANG Jun-bao DU | 2008 | Acta Pharmacologica Sinica2008，29，10： | 21 |
| 18 | Early nasogastric enteral nutrition for severe acute pancreatitis: A systematic review显示文摘AIM: To evaluate the effectiveness and safety of early nasogastric enteral nutrition (NGEN) for patients with severe acute pancreatitis (SAP). METHODS: We searched Cochrane Central Register of Controlled Trials (Issue 2, 2006), Pub-Medline (1966-2006), and references from relevant articles. We included randomized controlled trials (RCTs) only, which reported the mortality of SAP patients at least. Two reviewers assessed the quality of each trial and collected data independently. The Cochrane Collaboration’s RevMan 4.2.9 software was used for statistical analysis. RESULTS: Three RCTs were included, involving 131 patients. The baselines of each trial were comparable. Meta-analysis showed no significant differences in mortality rate of SAP patients between nasogastric and conventional routes (RR = 0.76, 95% CI = 0.37 and 1.55, P = 0.45), and in other outcomes, including time of hospital stay (weighted mean difference = -5.87, 95% CI = -20.58 and 8.84, P = 0.43), complication rate of infection (RR = 1.41, 95% CI = 0.62 and 3.23, P = 0.41) or multiple organ defi ciency syndrome (RR = 0.97, 95% CI = 0.27 and 3.47, P = 0.97), rate of admission to ICU (RR = 1.00, 95% CI = 0.48 and 2.09, P = 0.99) or conversion to surgery (RR = 0.66, 95% CI = 0.12 and 3.69, P = 0.64), as well as recurrence of re-feeding pain and adverse events associated with nutrition. CONCLUSION: Early NGEN is a breakthrough in the management of SAP. Based on current studies, early NGEN appears effective and safe. Since the available evidence is poor in quantity, it is hard to make an accurate evaluation of the role of early NGEN in SAP.Before recommendation to clinical practice, further high qualified, large scale, randomized controlled trials are needed. | Kun Jiang Xin-Zu Chen Qing Xia Wen-Fu Tang Lei Wang | 2007 | World Journal of Gastroenterology2007，13，39： | 21 |
| 19 | Changed clinical aspects of primary liver cancer in China during the past 30 years显示文摘BACKGROUND: Primary liver cancer (PLC) is one of the most frequently seen tumors in China. Thirty years ago, patients with PLC were often detected at relatively late stage, with a palpable mass or marked clinical symptoms and poor prognosis. In the past 30 years, the diagnosis and treatment of PLC have been greatly improved with better prognosis. METHODS: In order to study the changes of PLC during the 30 years, the clinical data of 3250 patients with PLC from 10 medical institutions of China were collected, ana- lyzed , and compared with those of 3254 PLC patients be- fore the 30 years. RESULTS: In the 3250 patients aged 1-80 years, with an average age of 49.1 years, the male to female ratio (2.3:1) was lower than that before the 30 years. 73.5% of the 3250 patients sought medical advice within 3 months after the onset of the disease in contrast to 63.8% before the 30 years. Compared with those patients before the 30 years the symptoms and signs were alleviated generally. The HBsAg positive rate was 81.0%, but the HCV-Ab positive rate was 13.2%. The AFP level in 75% of patients was elevated, but in the remaining 25% was normal. 1912 patients (58.8%) were confirmed pathologically. Among them 1755 patients (91.8%) had hepatocellular carcinoma. The overall resec- tion rate was 46.3%. Those who had early, middle, late stage carcinoma accounted for 29.9%, 51.5%, and 18.6%respectively in contrast to 0.4%, 47.0%, and 52.6% repor- ted before the 30 years. The 1-, 3-, 5-year survival rates of the patients were 66.1%, 39.7%, and 32.5% respectively, whereas 93.5%, 70.1%, and 59.1% for the early stage pa- tients, and 65.3%, 30.5%, and 23.5% for the middle stage patients. The half and 1-year survival rates of the late stage patients were 52.5%, and 14.7%, respectively. CONCLUSION: Comparison with the clinical data before and after the 30 years show that PLC can be diagnosed ear- ly. More PLC patients tend to undergo resection while re- ceiving a better conservative treatment, which ensures a prognosis. | Bing-Hui Yang, Jing-Lin Xia, Li-Wen Huang, Zhao-You Tang, Ming-Shan Chen, Jin-Qing Li, An-Min Liang, Qin-Guo Mo, Hui-Shan Lu, Chao-Liu Dai, Lu-Nan Yan, Zhi-Jian Yu, Rong-Sheng Rao, Le-Qun Li, Zhi-Xiong Su, Zhuang-Wei Fang Shanghai, China Liver Cancer Institute & Zhongshan Hospital, Fudan University, Shanghai 200032, China Tumor Hospital, Zhongshan University, Guangzhou 510000, China Tumor Hospital, Guangxi Medical Universi- ty, Nanning 530000, China Xiehe Hospital, Fujian Medical University, Fuzhou 350000, China Second Hos- pital, Chinese Medical University, Shenyang 110000, China Huaxi Hospital, Sichuan University, Chengdu 610041, China Hospital Affiliated to Nantong Medical University, Nantong 226000 , China Second Hospital, Jiangxi Medical University, Nanchang 330000 , China First Hospital Affiliated to Guangxi Medical University, Nanning 530000 , China People’s Hospital of Hainan Province, Haikou 570000, China | 2004 | Hepatobiliary & Pancreatic Diseases International2004，3，2： | 20 |
| 20 | Special Section:SARS-CoV-2 Preliminary evidence from a multicenter prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19显示文摘Effective therapies are urgently needed for the SARS-CoV-2 pandemic.Chloroquine has been proved to have antiviral effect against coronavirus in vitro.In this study,we aimed to assess the efficacy and safety of chloroquine with different doses in COVID-19.In this multicenter prospective observational study,we enrolled patients older than 18 years old with confirmed SARS-CoV-2 infection excluding critical cases from 12 hospitals in Guangdong and Hubei Provinces.Eligible patients received chloroquinephosphate s00 mg,orally,once(half dose)or twice(full dose)daily.Patients treated with non-chloroquine therapy were included as historical controls.The primary endpoint is the time to undetectable viral RNA.Secondary outcomes include the proportion of patients with undetectable viral RNA by day 10 and 14,hospitalization time,duration of fever,and adverse events.A total of 197 patients completed chloroquine treatment,and 176patients were included as historical controls.The median time to achieve an undetectable viral RNA was shorter in chloroquine than in non-chloroquine(absolute difference in medians-6.0 days;95%CI-6.0 to—4.0).The duration of fever is shorter in chloroquine(geometric mean ratio 0.6;95%CIO.5 to 0.8).No serious adverse events were observed in the chloroquine group.Patients treated with half dose experienced lower rate of adverse events than with full dose.Although randomized trials are needed for further evaluation,this study provides evidence for safety and efficacy of chloroquine in COVID-19 and suggests that chloroquine can be a cost-effective therapy for combating the COVID-19 pandemic. | Mingxing Huang Man Li Fei Xiao Pengfei Pang Jiabi Liang Tiantian Tang Shaoxuan Liu Binghui Chen Jingxian Shu Yingying You Yang Li Meiwen Tang Jianhui Zhou Guanmin Jiang Jingfen Xiang Wenxin Hong Songmei He Zhaoqin Wang Jianhua Feng Changqing Lin Yinong Ye Zhilong Wu Yaocai Li Bei Zhong Ruilin Sun Zhongsi Hong Jing Liu Huili Chen Xiaohua Wang Zhonghe Li Duanqing Pei Lin Tian Jinyu Xia Shanping Jiang Nanshan Zhong Hong Shan | 2020 | National Science Review2020，7，9： | 20 |
您所在的机构暂未开通此部分的功能，请联系管理员